CareRx Corp's stock has seen a notable decline this past week, with a 7.44% drop as investors digest recent earnings and dividend announcements.
CareRx Corp (CRRX.TO) has experienced a challenging week in the market, with its stock price falling by 7.44%. The company recently announced its financial results for Q2 2026, which highlighted increased revenue but did not seem to provide the boost investors were hoping for. Here’s a closer look at the current situation surrounding CareRx Corp's stock.
Advertisement
CareRx Corp
CRRX.TO
CRRX.TO
CareRx Corp
WealthAwesomeAdvertisement
Market cap
$213.82M
P/E
8.0x
Div. yield
2.39%
Div. / share
$0.08
52W high
$3.95
52W low
$2.82
1W change
-7.44%
Beta
0.60
Analyst Price Targets
Based on analyst covering CRRX
Wall Street analysts forecast CRRX stock price to rise 53.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.14
+53.1% Upside
Current Price
C$3.36
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRRX's historical volatility
30-Day Vol
27.1%
Annualized
90-Day Vol
26.7%
Annualized
Trend (90d)
-14.7%
Annualized drift
90d Mean
C$3.19
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.30 | C$3.01 – C$3.63 |
| 60 trading days | C$3.24 | C$2.84 – C$3.70 |
| 90 trading days | C$3.19 | C$2.71 – C$3.75 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Despite a recent dip in stock price and volume, CareRx Corp continues to show potential through its financial results and dividend announcements. Investors should monitor the company's upcoming earnings calls for further insights.
CareRx Corp's stock is down 7.44% this week, closing at C$3.37.
The stock has a 52-week range of C$2.82 to C$3.95, currently sitting at 49% of this range, highlighting its recent struggles.
Bull case
CareRx Corp has reported an increase in revenue and the number of beds serviced, indicating growth potential. The company’s low P/E ratio of 8.02 suggests it may be undervalued, and analysts are optimistic about its future performance.
Bear case
The recent decline in stock price and lower trading volume compared to the 20-day average may indicate waning investor interest. Additionally, the stock is trading below its 200-day moving average, which could signal further challenges ahead.
Recent Price Action
Advertisement
CareRx Corp's stock closed at C$3.37, reflecting a 0.30% decline on the day and a significant 7.44% drop over the past week. The stock has struggled year-to-date, down 13.40%, indicating broader challenges in market sentiment.
Company News and Catalysts
Recent headlines indicate that CareRx announced its Q2 2026 financial results, reporting increased revenue of $93.6 million and an average of 91,719 beds serviced. Additionally, the company declared a dividend of CAD$0.022 per share, signaling a commitment to returning value to shareholders. However, these announcements did not seem to generate positive momentum in the stock price.
Technical Picture
Currently, CareRx trades near its 50-day moving average of C$3.35, which it is slightly above by 0.7%. However, it is trading below its 200-day moving average of C$3.61, suggesting potential bearish momentum. The stock's beta of 0.60 indicates lower volatility compared to the market. Volume for the day was 4,405 shares, significantly below the 20-day average of 11,365 shares, reflecting reduced trading activity.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
